您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Aleplasinin
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Aleplasinin
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Aleplasinin图片
CAS NO:481629-87-2
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议

产品介绍
Aleplasinin 是一种口服有效的、可透过血脑屏障的、选择性的 SERPINE1 (PAI-1,纤溶酶原激活物抑制剂 -1) 抑制剂。Aleplasinin 增加淀粉样蛋白 -β (Aβ) 分解代谢,改善淀粉样蛋白相关病理。Aleplasinin 可改善记忆缺陷。Aleplasinin 可用于阿尔茨海默病的研究。
Cas No.481629-87-2
别名PAZ-417
分子式C28H27NO3
分子量425.52
溶解度DMSO : 250 mg/mL (587.52 mM; Need ultrasonic)
储存条件4°C, protect from light
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Aleplasinin is an orally active, potent, BBB-penetrated and selectiveSERPINE1 (PAI-1, Plasminogen activator inhibitor-1) inhibitor. Aleplasinin increases amyloid-β (Aβ) catabolism and ameliorates amyloid-related pathology. Aleplasinin improves memory deficiency. Aleplasinin can be used for Alzheimer's disease research[1][2].

[1]. Zhao J, Pei G. Evoking plasmin for beta-amyloid clearance. Cell Res. 2008 Aug;18(8):803-4.
[2]. Kellici TF, Pilka ES, Bodkin MJ. Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19. Trends Pharmacol Sci. 2021 Jun;42(6):431-433.